Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study

Shanshan Liu, Ju Li, Yongsheng Li, Yan Liu, Kai Wang, Wenyou Pan Department of Rheumatology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of ChinaCorrespondence: Shanshan LiuDepartment of Rheumatology, The Affiliated Huaian No.1 People’s Hospi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liu S, Li J, Li Y, Liu Y, Wang K, Pan W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/c1bbe11faa864f659207ecbf7bbb8ee6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c1bbe11faa864f659207ecbf7bbb8ee6
record_format dspace
spelling oai:doaj.org-article:c1bbe11faa864f659207ecbf7bbb8ee62021-11-21T19:08:51ZAssociation Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study1178-7066https://doaj.org/article/c1bbe11faa864f659207ecbf7bbb8ee62021-11-01T00:00:00Zhttps://www.dovepress.com/association-between-the-interferon--874-ta-polymorphism-and-the-risk-a-peer-reviewed-fulltext-article-PGPMhttps://doaj.org/toc/1178-7066Shanshan Liu, Ju Li, Yongsheng Li, Yan Liu, Kai Wang, Wenyou Pan Department of Rheumatology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of ChinaCorrespondence: Shanshan LiuDepartment of Rheumatology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of ChinaEmail drshanshanliu@163.comBackground: Interferon-gamma (IFN-γ) is a pivotal cytokine involved in the development of systemic lupus erythematosus (SLE). The IFN-γ +874 T/A polymorphism has been shown to be related to the susceptibility to SLE in other races, but this has not been investigated in the Chinese Han population.Methods: We designed this study to interpret the potential correlation between this polymorphism and SLE risk in a Chinese Han population. We included 374 SLE patients and 405 controls in this study. Odds ratios and relevant 95% confidence intervals were figured out to evaluate the potential strength of the association.Results: Data revealed that the IFN-γ +874 T/A polymorphism showed an association with an enhanced risk of SLE in this Chinese Han population. TA or TA +AA genotype carriers showed an increased risk of developing SLE. Subgroup analyses found that this polymorphism elevated the risk of SLE among females. Additionally, this polymorphism was associated with clinical manifestations of SLE including lupus nephritis, proteinuria, anti-dsDNA antibodies, anti-Sm antibodies, and SLICC/ACR damage index. Furthermore, we conducted a meta-analysis and found that this polymorphism was associated with the risk of SLE, especially among Asians.Conclusion: Totally, this study detects that the IFN-γ +874 T/A polymorphism is related to the risk and clinical manifestations of SLE in a Chinese Han population.Keywords: interferon-gamma, systemic lupus erythematosus, case–control study, +874 T/A polymorphismLiu SLi JLi YLiu YWang KPan WDove Medical Pressarticleinterferon-gammasystemic lupus erythematosuscase-control study+874 t/a polymorphismTherapeutics. PharmacologyRM1-950ENPharmacogenomics and Personalized Medicine, Vol Volume 14, Pp 1475-1482 (2021)
institution DOAJ
collection DOAJ
language EN
topic interferon-gamma
systemic lupus erythematosus
case-control study
+874 t/a polymorphism
Therapeutics. Pharmacology
RM1-950
spellingShingle interferon-gamma
systemic lupus erythematosus
case-control study
+874 t/a polymorphism
Therapeutics. Pharmacology
RM1-950
Liu S
Li J
Li Y
Liu Y
Wang K
Pan W
Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
description Shanshan Liu, Ju Li, Yongsheng Li, Yan Liu, Kai Wang, Wenyou Pan Department of Rheumatology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of ChinaCorrespondence: Shanshan LiuDepartment of Rheumatology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huaian, People’s Republic of ChinaEmail drshanshanliu@163.comBackground: Interferon-gamma (IFN-γ) is a pivotal cytokine involved in the development of systemic lupus erythematosus (SLE). The IFN-γ +874 T/A polymorphism has been shown to be related to the susceptibility to SLE in other races, but this has not been investigated in the Chinese Han population.Methods: We designed this study to interpret the potential correlation between this polymorphism and SLE risk in a Chinese Han population. We included 374 SLE patients and 405 controls in this study. Odds ratios and relevant 95% confidence intervals were figured out to evaluate the potential strength of the association.Results: Data revealed that the IFN-γ +874 T/A polymorphism showed an association with an enhanced risk of SLE in this Chinese Han population. TA or TA +AA genotype carriers showed an increased risk of developing SLE. Subgroup analyses found that this polymorphism elevated the risk of SLE among females. Additionally, this polymorphism was associated with clinical manifestations of SLE including lupus nephritis, proteinuria, anti-dsDNA antibodies, anti-Sm antibodies, and SLICC/ACR damage index. Furthermore, we conducted a meta-analysis and found that this polymorphism was associated with the risk of SLE, especially among Asians.Conclusion: Totally, this study detects that the IFN-γ +874 T/A polymorphism is related to the risk and clinical manifestations of SLE in a Chinese Han population.Keywords: interferon-gamma, systemic lupus erythematosus, case–control study, +874 T/A polymorphism
format article
author Liu S
Li J
Li Y
Liu Y
Wang K
Pan W
author_facet Liu S
Li J
Li Y
Liu Y
Wang K
Pan W
author_sort Liu S
title Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
title_short Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
title_full Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
title_fullStr Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
title_full_unstemmed Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
title_sort association between the interferon-γ +874 t/a polymorphism and the risk and clinical manifestations of systemic lupus erythematosus: a preliminary study
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/c1bbe11faa864f659207ecbf7bbb8ee6
work_keys_str_mv AT lius associationbetweentheinterferongamma874tapolymorphismandtheriskandclinicalmanifestationsofsystemiclupuserythematosusapreliminarystudy
AT lij associationbetweentheinterferongamma874tapolymorphismandtheriskandclinicalmanifestationsofsystemiclupuserythematosusapreliminarystudy
AT liy associationbetweentheinterferongamma874tapolymorphismandtheriskandclinicalmanifestationsofsystemiclupuserythematosusapreliminarystudy
AT liuy associationbetweentheinterferongamma874tapolymorphismandtheriskandclinicalmanifestationsofsystemiclupuserythematosusapreliminarystudy
AT wangk associationbetweentheinterferongamma874tapolymorphismandtheriskandclinicalmanifestationsofsystemiclupuserythematosusapreliminarystudy
AT panw associationbetweentheinterferongamma874tapolymorphismandtheriskandclinicalmanifestationsofsystemiclupuserythematosusapreliminarystudy
_version_ 1718418725402574848